We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+13.29%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.5B
AUM Growth
+$748M
Cap. Flow
+$681M
Cap. Flow %
45.46%
Top 10 Hldgs %
71.8%
Holding
659
New
195
Increased
97
Reduced
113
Closed
226

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$21.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$17M
3
AVGO icon
Broadcom
AVGO
+$16.6M
4
MRVL icon
Marvell Technology
MRVL
+$14.3M
5
TMUS icon
T-Mobile US
TMUS
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 25.98%
2 Technology 3.97%
3 Financials 3.94%
4 Consumer Discretionary 2.88%
5 Industrials 1.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPGP icon
276
IPG Photonics
IPGP
$3.61B
$410K 0.03%
4,331
SANM icon
277
Sanmina
SANM
$10.7B
$410K 0.03%
+7,153
New +$423K
MANH icon
278
Manhattan Associates
MANH
$11.4B
$408K 0.03%
3,363
+1,812
+117% +$223K
WMT icon
279
Walmart Inc
WMT
$897B
$407K 0.03%
+8,601
New +$408K
SOHU
280
Sohu.com
SOHU
$376M
$406K 0.03%
29,594
FSP
281
Franklin Street Properties
FSP
$45.3M
$405K 0.03%
148,253
+53,846
+57% +$149K
ATR icon
282
AptarGroup
ATR
$8.5B
$404K 0.03%
3,674
-6,870
-65% -$706K
HEI icon
283
HEICO Corp
HEI
$50.9B
$402K 0.03%
+2,616
New +$407K
CGNT icon
284
Cognyte Software
CGNT
$689M
$397K 0.03%
+127,751
New +$375K
CRNC icon
285
Cerence
CRNC
$403M
$396K 0.03%
21,379
-4,809
-18% -$82.4K
PRLD icon
286
Prelude Therapeutics
PRLD
$385M
$395K 0.03%
65,453
-20,539
-24% -$132K
ZH
287
Zhihu
ZH
$284M
$394K 0.03%
+50,530
New +$354K
AGIO icon
288
Agios Pharmaceuticals
AGIO
$1.95B
$392K 0.03%
13,959
-9,501
-40% -$268K
VKTX icon
289
Viking Therapeutics
VKTX
$4.02B
$391K 0.03%
41,622
-159,411
-79% -$712K
RVLV icon
290
Revolve Group
RVLV
$1.73B
$391K 0.03%
+17,574
New +$422K
INVX
291
Innovex International
INVX
$2.04B
$391K 0.03%
+14,394
New +$343K
TDW icon
292
Tidewater
TDW
$4.46B
$391K 0.03%
+10,612
New +$323K
GDX icon
293
VanEck Gold Miners ETF
GDX
$27.6B
$384K 0.03%
+13,400
New +$358K
ITW icon
294
Illinois Tool Works
ITW
$83.9B
$384K 0.03%
1,741
-3,827
-69% -$815K
SPWH icon
295
Sportsman's Warehouse
SPWH
$46.4M
$369K 0.02%
39,231
-15,795
-29% -$145K
AGYS icon
296
Agilysys
AGYS
$3.02B
$367K 0.02%
+4,634
New +$295K
DXLG icon
297
Destination XL Group
DXLG
$31.2M
$365K 0.02%
+54,060
New +$347K
AMGN icon
298
Amgen
AMGN
$226B
$361K 0.02%
+1,373
New +$368K
SBNY
299
DELISTED
Signature Bank
SBNY
$360K 0.02%
3,123
-664
-18% -$91.3K
AVNS
300
DELISTED
Avanos Medical
AVNS
$355K 0.02%
13,108
+2,048
+19% +$50.1K

Similar funds

Caxton Associates (New York)'s Q4 2022 Portfolio in Review

As of Q4 2022, Caxton Associates (New York) held 659 positions worth $1.5B, up 100% from $751M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Caxton Associates (New York) deployed $681M of net new capital in Q4 2022, opening 195 new positions and adding to 97 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,356,392 shares worth $519M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Amazon, an estimated $21.3M trimmed.

  • Caxton Associates (New York)'s largest Q4 2022 buy was State Street SPDR S&P 500 ETF Trust: 1,356,392 shares worth $519M.
  • Caxton Associates (New York) added most to Visa in Q4 2022, an estimated $13M increase.
  • Caxton Associates (New York)'s biggest Q4 2022 reduction was Amazon, cutting an estimated $21.3M.
  • Caxton Associates (New York) fully exited Broadcom in Q4 2022, selling an estimated $16.6M.
  • Caxton Associates (New York)'s ten largest holdings make up 72% of its $1.5B portfolio in Q4 2022.
  • Caxton Associates (New York) opened 195 new positions and closed 226 in Q4 2022.
  • Caxton Associates (New York)'s portfolio value rose 100% quarter-over-quarter to $1.5B.

Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.